Lv3
266 积分 2024-07-15 加入
Ultrasonography in the prediction of gout flares: a 12-month prospective observational study
1天前
待确认
Company Sponsored Platform Trials: Recommendations and Lessons Learned from Cross-Industry Interviews
1个月前
已完结
Macrophage activation syndrome
3个月前
已完结
Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer
4个月前
已完结
Clinicopathological features and resistance mechanisms in HIP1‐ALK ‐rearranged lung cancer: A multicenter study
4个月前
已完结
LenLenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
8个月前
已完结
Thinking outside the box: non-canonical targets in multiple sclerosis
10个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
10个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
10个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
11个月前
已完结
皖公网安备34019202002308
